In addition, NEDD4 mediates LGR4/5 and DVL2 lysosomal and proteasomal degradation, resulting in inactivation of the WNT/β-catenin signaling pathway and inhibition of the susceptibility and progression of colorectal tumors [36]. This evidence concerns the gene NEDD4 and colorectal neoplasm.